Desoxycortone enanthate | 1420-68-4

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: Desoxycortone enanthate
• 英文别名: [2-[(8S,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] heptanoate
• CAS: 1420-68-4
• 化学式: C₂₈H₄₂O₄
• 分子量: 442.6
• InChiKey: UNGDDFDVVHFRQA-FTIQDDARSA-N

物化性质

• 沸点：
  559.6±50.0 °C(Predicted)
• 密度：
  1.09±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  5.5
• 重原子数：
  32
• 可旋转键数：
  9
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.82
• 拓扑面积：
  60.4
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• Lipid-linked prodrugs
  申请人：The University of British Columbia

  公开号：US10780174B2

  公开（公告）日：2020-09-22

  This invention provides lipid-linked prodrugs having structures as set out herein. Uses of such lipid-linked prodrug compounds for treatment of various indications, and methods for making and using lipid-linked prodrugs are also provided.

  本发明提供了具有本文所述结构的脂联原药。本发明还提供了这种脂联原药化合物用于治疗各种适应症的用途，以及脂联原药的制造和使用方法。
• LIPID-LINKED PRODRUGS
  申请人：The University of British Columbia

  公开号：EP3394080A1

  公开（公告）日：2018-10-31
• Lipid-Linked Prodrugs
  申请人：The University of British Columbia

  公开号：US20190151458A1

  公开（公告）日：2019-05-23

  This invention provides lipid-linked prodrugs having structures as set out herein. Uses of such lipid-linked prodrug compounds for treatment of various indications, and methods for making and using lipid-linked prodrugs are also provided.
• [EN] LIPID-LINKED PRODRUGS<br/>[FR] PROMÉDICAMENTS LIÉS À DES LIPIDES
  申请人：UNIV BRITISH COLUMBIA

  公开号：WO2017106957A1

  公开（公告）日：2017-06-29

  This invention provides lipid-linked prodrugs having structures as set out herein. Uses of such lipid-linked prodrug compounds for treatment of various indications, and methods for making and using lipid-linked prodrugs are also provided.